A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914472 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Aifang Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Wasps. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial peptides have gradually attracted interest as promising alternatives to conventional agents to control the worldwide health threats posed by antibiotic resistance and cancer. Crabrolin is a tridecapeptide extracted from the venom of the European hornet (Vespa crabro). Its antibacterial and anticancer potentials have been underrated compared to other peptides discovered from natural resources. Herein, a series of analogs were designed based on the template sequence of crabrolin to study its structure–activity relationship and enhance the drug’s potential by changing the number, type, and distribution of charged residues. The cationicity-enhanced derivatives were shown to have improved antibacterial and anticancer activities with a lower toxicity. Notably, the double-arginine-modified product, crabrolin-TR, possessed a potent capacity against Pseudomonas aeruginosa (minimum inhibitory concentration (MIC) = 4 μM), which was around thirty times stronger than the parent peptide (MIC = 128 μM). Furthermore, crabrolin-TR showed an in vivo treatment efficacy in a Klebsiella-pneumoniae-infected waxworm model and was non-toxic under its maximum MBC value (MIC = 8 μM), indicating its therapeutic potency and better selectivity. Overall, we rationally designed functional peptides by progressively increasing the number and distribution of charged residues, demonstrating new insights for developing therapeutic molecules from natural resources with enhanced properties, and proposed crabrolin-TR as an appealing antibacterial and anticancer agent candidate for development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
- School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
ORCID-Profile: Aifang Yao, Mei Zhou, Tianbao Chen, Lei Wang
Zitieren
APA
Yao, A., Ma, Y., Sun, R., Zou, W., Chen, X., Zhou, M., Ma, C., Chen, T., Shaw, C., & Wang, L. (2023). A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914472
Vancouver
Yao A, Ma Y, Sun R, Zou W, Chen X, Zhou M, et al. A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914472
BibTeX
@article{Yao2023,
author = {Yao, Aifang and Ma, Yingxue and Sun, Ruize and Zou, Wanchen and Chen, Xiaoling and Zhou, Mei and Ma, Chengbang and Chen, Tianbao and Shaw, Chris and Wang, Lei},
title = {A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914472}
}
EUVIMED